絞り込み

16645

広告

新型ウイルス対応医師ら職場で“バイ菌”扱い 学会が抗議声明

新型コロナウイルスの集団感染が起きたクルーズ船などで、対応を行った医師や看護師らが職場などで不当な扱いを受けているとして、災害対応を行う医療関係者でつくる学会が...

  1. 新型肺炎 インフルエンザ治療薬など使用 ...
  2. 新型肺炎 クルーズ下船後に陽性 栃木の6...
  3. 【動画】「dry cough」の意味を予...
  4. G20開幕 肺炎議題に 世界経済リスク、...

ニュース一覧

「"Tasian SK "[Author]」の検索結果

50件中 1件~20件表示    検索結果をPubMedで見る PubMedで見る

Clinical diagnostics and treatment strategies for Philadelphia chromosome-like acute lymphoblastic leukemia.

Transient atypical monocytosis after α/β T-cell-depleted haploidentical hematopoietic stem cell transplantation.

The future of cellular immunotherapy for childhood leukemia.

Opportunities for immunotherapy in childhood acute myeloid leukemia.

Opportunities for immunotherapy in childhood acute myeloid leukemia.

Development and Clinical Validation of a Large Fusion Gene Panel for Pediatric Cancers.

Clinical utility of custom-designed NGS panel testing in pediatric tumors.

A parsimonious 3-gene signature predicts clinical outcomes in an acute myeloid leukemia multicohort study.

Aberrant splicing in B-cell acute lymphoblastic leukemia.

Targeting EIF4E signaling with ribavirin in infant acute lymphoblastic leukemia.

Aberrant splicing in B-cell acute lymphoblastic leukemia.

Generation of a human Juvenile myelomonocytic leukemia iPSC line, CHOPi001-A, with a mutation in CBL.

Acute myeloid leukemia chimeric antigen receptor T-cell immunotherapy: how far up the road have we traveled?

Mutation-specific signaling profiles and kinase inhibitor sensitivities of juvenile myelomonocytic leukemia revealed by induced pluripotent stem cells.

Clinical efficacy of ruxolitinib and chemotherapy in a child with Philadelphia chromosome-like acute lymphoblastic leukemia with GOLGA5-JAK2 fusion and induction failure.

Inhibition of mTORC1/C2 signaling improves anti-leukemia efficacy of JAK/STAT blockade inrearranged and/ordriven Philadelphia chromosome-like acute B-cell lymphoblastic leukemia.

Targeting Leukemia Stem Cells in the Bone Marrow Niche.

mTOR inhibition enhances efficacy of dasatinib in-rearranged Ph-like B-ALL.

Targeting FLT3 Signaling in Childhood Acute Myeloid Leukemia.

How is the Ph-like signature being incorporated into ALL therapy?

  1. 1
  2. 2
  3. 3
Sort by
※並べ替えは表示に時間がかかります